By using NCI-H727 cells xenograft model of NETs, Yin W et al. showed that 177Lu-DOTATATE PRRT led to increased infiltration of CD86+ cells and CD49b+/FasL+ NK cells in tumor tissues, which is capable of tumor killing 93. Here, CD86 is linked to neoplasm.